<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03294187</url>
  </required_header>
  <id_info>
    <org_study_id>2017-00948</org_study_id>
    <nct_id>NCT03294187</nct_id>
  </id_info>
  <brief_title>Encouragement-induced Movement Therapy in Daily Life</brief_title>
  <acronym>ISEAR</acronym>
  <official_title>Encouragement-induced Movement Therapy in Daily Life - a Randomized Controlled, Assessor-blinded Multi-center Trial in Stroke Patients With a Unilateral Hemiparesis, Using a Wrist-worn Tracking and Feedback Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>yband therapy AG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Swiss Federal Institute of Technology in Zurich (ETH Zurich)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stroke places a major burden on health care and society. It often leads to a hemiparesis.&#xD;
      Intensive stroke rehabilitation speeds up recovery. In daily practice, the financial and/or&#xD;
      human resources to provide this intensive rehabilitation are often lacking. Applying&#xD;
      modern-day tracking and feedback technology to encourage a self-administered, context&#xD;
      specific training is expected to offer significant potential to increase intensity of&#xD;
      practice. Up until now, there has been no randomized trial examining the effect of such an&#xD;
      intervention on daily arm usage.&#xD;
&#xD;
      The primary objective of this study is to determine the effect of wearing an activity&#xD;
      tracking and multimodal feedback device for six weeks on self-reported daily life use of the&#xD;
      paretic arm after stroke, when compared to control group stroke subjects wearing a&#xD;
      hardware-wise identical sham device providing no feedback. The secondary aim is to examine&#xD;
      compliance to use the device and the quantitative, qualitative and functional improvement of&#xD;
      the paretic arm. It is hypothesized that participants in the experimental group show a higher&#xD;
      change in self-reported daily life use of the paretic arm when compared to the control group&#xD;
      both post intervention and at 6-week follow-up.&#xD;
&#xD;
      ISEAR is a multicenter, assessor-blinded randomized controlled trial of 62 subjects beyond&#xD;
      the first 3 months poststroke.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 25, 2017</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Motor Activity Log - 14, Amount of Use sub scale</measure>
    <time_frame>Post-intervention (6 weeks)</time_frame>
    <description>Self-reported amount of upper limb use in daily life</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fugl-Meyer Assessment, Upper Extremity sub scale</measure>
    <time_frame>Post-intervention (6 weeks)</time_frame>
    <description>Upper limb motor function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fugl-Meyer Assessment, Upper Extremity sub scale</measure>
    <time_frame>Follow-up (12 weeks)</time_frame>
    <description>Upper limb motor function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test</measure>
    <time_frame>Post-intervention (6 weeks)</time_frame>
    <description>Upper limb capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test</measure>
    <time_frame>Follow-up (12 weeks)</time_frame>
    <description>Upper limb capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Rankin Scale</measure>
    <time_frame>Post-intervention (6 weeks)</time_frame>
    <description>Global Disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Rankin Scale</measure>
    <time_frame>Follow-up (12 weeks)</time_frame>
    <description>Global Disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol five dimensions five levels questionnaire</measure>
    <time_frame>Post-intervention (6 weeks)</time_frame>
    <description>Quality of Life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol five dimensions five levels questionnaire</measure>
    <time_frame>Follow-up (12 weeks)</time_frame>
    <description>Quality of Life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor Activity Log - 14, Quality of Movement sub scale</measure>
    <time_frame>Post-intervention (6 weeks)</time_frame>
    <description>Self-reported quality of upper limb use in daily life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor Activity Log - 14, Quality of Movement sub scale</measure>
    <time_frame>Follow-up (12 weeks)</time_frame>
    <description>Self-reported quality of upper limb use in daily life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor Activity Log - 14, Amount of Use sub scale</measure>
    <time_frame>Follow-up (12 weeks)</time_frame>
    <description>Self-reported amount of upper limb use in daily life</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Global Rating of Perceived Change</measure>
    <time_frame>Post-intervention (6 weeks)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Global Rating of Perceived Change</measure>
    <time_frame>Follow-up (12 weeks)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Concomitant movement therapy</measure>
    <time_frame>Post-intervention (6 weeks)</time_frame>
    <description>Time spend at Movement therapy (e.g., Physiotherapy, Occupational therapy)</description>
  </other_outcome>
  <other_outcome>
    <measure>Concomitant movement therapy</measure>
    <time_frame>Follow-up (12 weeks)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Baseline (0 week)</time_frame>
    <description>Safety</description>
  </other_outcome>
  <other_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Post-intervention (6 weeks)</time_frame>
    <description>Safety</description>
  </other_outcome>
  <other_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Follow-up (12 weeks)</time_frame>
    <description>Safety</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Monitoring and Feedback</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will use two wrist-worn wearables over a period of 6 weeks. Patients will receive multimodal (vibrotactile and visual) feedback.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Monitoring</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Study subjects will use identical devices over a period of 6 weeks. Patients will *not* receive multimodal feedback.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wrist-worn wearables</intervention_name>
    <description>See arm/group description.</description>
    <arm_group_label>Monitoring</arm_group_label>
    <arm_group_label>Monitoring and Feedback</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Above 18 years of age with unilateral stroke and residual hemiparesis leading to a&#xD;
             decrease of arm function after completion of all inpatient rehabilitation (at least 90&#xD;
             days post stroke)&#xD;
&#xD;
          -  Ability to lift arm against gravity (&gt;30 degrees flexion or abduction)&#xD;
&#xD;
          -  Ability to don/doff the devices on both wrists independently or with assistance of a&#xD;
             caregiver&#xD;
&#xD;
          -  Ability to give informed consent as documented by signature&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Major untreated depression&#xD;
&#xD;
          -  Severe cognitive impairment&#xD;
&#xD;
          -  Suffering from comprehensive aphasia&#xD;
&#xD;
          -  Severely impaired sensation (unable to feel a soft touch on the dorsal side of their&#xD;
             paretic wrist with closed eyes)&#xD;
&#xD;
          -  Other major comorbidities (e.g., cardiopulmonary disease, renal failure, hepatic&#xD;
             dysfunction, orthopedic disorders, etc.)&#xD;
&#xD;
          -  Expected hospitalization during study period&#xD;
&#xD;
          -  Known intolerance to device material&#xD;
&#xD;
          -  Known or suspected non-compliance, drug or alcohol abuse&#xD;
&#xD;
          -  The investigator, his/her family members, employees, and other dependent persons&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas R Luft, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeremia PO Held</last_name>
    <phone>+41442555645</phone>
    <email>jeremia.held@uzh.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Janne M Veerbeek, PhD</last_name>
    <phone>+41442555645</phone>
    <email>janne.veerbeek@uzh.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cereneo, Center For Neurology and Rehabilitation</name>
      <address>
        <city>Vitznau</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Leopold Zizlsperger, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zürcher RehaZentrum Wald</name>
      <address>
        <city>Wald</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonella Palla, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeremia Held</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 12, 2017</study_first_submitted>
  <study_first_submitted_qc>September 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2017</study_first_posted>
  <last_update_submitted>February 5, 2020</last_update_submitted>
  <last_update_submitted_qc>February 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Upper Extremity</keyword>
  <keyword>Feedback</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

